The collaboration is a valuable step toward supporting more patients to maintain healthy routines post-surgery and preventing medical complications in the long term. Research shows that >75% of all patients develop one or more deficiencies in one year after a Sleeve Gastrectomy.

We are active in more than 29 countries conducting medical research and developing personalized supplements to decrease deficiencies after bariatric surgery. Joining forces with Baricol allows us to reach new regions and deliver innovative solutions to improve medical results in the long term.

Haris Fazlic, CEO Baricol: “FitForMe is a leading example in bariatric supplements in Europe and has always been an inspiration and a source of knowledge for Baricol. We’ve proudly reviewed and learned from the extensive research done by FitForMe. We are looking forward to jointly meeting the challenge of supplementation with our shared base in science and patient products”.

Baricol is the leading brand in the Scandinavian region and has developed the innovative digital patient application BariBuddy. This is a solution for the long-term challenge of adherence to daily supplementation and healthy routines post-surgery.

We aim to make such innovations available on a global scale.

Our journey to provide more patients and healthcare professionals with scientifically proven solutions and a worldwide platform has just begun. We will continue to seek out more ways to increase our impact and support as many patients and healthcare professionals as possible.

At this moment, the acquisition will not have a direct impact on the products and services offered by FitForMe and Baricol Bariatrics. All products and services can be advised and applied in practice as known. In the event of any changes, we will inform you promptly.